Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Drug could cut asthma therapy

Article Abstract:

Researchers have reported on the development of a new, experimental drug designated as IgE that could eliminate the need for other medications for many of 17 million asthmatics in the US and allow other people to considerably reduce their intake of standard drugs. Two studied have indicated that IgE prevents asthma attacks in adults and children without major side effects when take by injection once a month or every two weeks. The drug also stops asthma attacks before they begin, preventing damage from scarring to airways. Prior research has indicated that IgE also relieves allergies.

Author: Sternberg, Steve
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
Product development, Antiasthmatic Preparations, Antiasthmatic agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Airline audit echoes FAA's

Article Abstract:

Alaska Airlines Inc, on Jul 6, 2000, made public an audit that shows the company has undermanned maintenance and safety operations, low employee morale, and policies and proceedings requiring overhaul. The audit prompted the airline to implement extensive changes that include the hiring of 82 more mechanics. In June, the Federal Aviation Administration threatened to shut down Alaska's heavy-maintenance facility when the agency's audit indicated that the carrier outgrew itself and that it failed to fill vital safety positions and document needed repair to its fleet.

Author: Sternberg, Steve
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
Scheduled Air Transportation, Public affairs, Scheduled Airlines, Alaska Airlines Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug may cut heart death risks

Article Abstract:

Ramipril, currently prescribed for high blood pressure, significantly reduces the risk of having a heart attack or stroke, according to a five- year study. A volunteer group who took the drug had a combined rate of heart attack, stroke and heart disease death of 13.9%, compared with 17.5% for a placebo group. Researchers speculate that the drug works by improving the health of blood vessel walls.

Author: Sternberg, Steve
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1999
Product information, Cardiovascular Preparations

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States
Similar abstracts:
  • Abstracts: Microsoft on trial. Change ahead for mobile phones
  • Abstracts: Patent assurance helps revive ailing biotech, health stocks. Tax hotline callers worried over stocks
  • Abstracts: Playboy boots publishng executives as ad market wanes. Hip-hop magazine gets fiery start, good and bad. 'Women's Sports' folds as niche gets redefined
  • Abstracts: First year of Net index teaches tough lessons. Broadband's slow start strangles shares. AOL link is a pothole for some, but not for TheStreet.com
  • Abstracts: Failing anchor stores punch holes in malls. Now, harried shoppers can take control at supermarkets. Like, be hip or be gone in teen clothes market
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.